Last reviewed · How we verify
Placebo Comparator (for hCG)
A placebo comparator has no active pharmacological mechanism and serves as an inert control in clinical trials.
A placebo comparator has no active pharmacological mechanism and serves as an inert control in clinical trials. Used for Control comparator in clinical trials evaluating hCG (human chorionic gonadotropin) treatments.
At a glance
| Generic name | Placebo Comparator (for hCG) |
|---|---|
| Also known as | IVF media, "Global" media-trademark |
| Sponsor | Michigan State University |
| Modality | Small molecule |
| Therapeutic area | Reproductive/Endocrinology |
| Phase | FDA-approved |
Mechanism of action
Placebo comparators are inactive substances used in randomized controlled trials to establish the baseline effect of a disease condition and distinguish true drug efficacy from placebo response. They contain no active pharmaceutical ingredient and are designed to be indistinguishable from the active treatment in appearance and administration route.
Approved indications
- Control comparator in clinical trials evaluating hCG (human chorionic gonadotropin) treatments
Common side effects
Key clinical trials
- Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1 (PHASE3)
- Intravenous Immunoglobulin and Prednisolone for RPL After ART. (PHASE2)
- Comparing the Effects of Oral Contraceptive Pills Versus Metformin (PHASE3)
- hCG Priming in Women With Diminished Ovarian Reserve (PHASE3)
- Bioenergetic Effect of Pioglitazone in CLD-PH (PHASE2)
- Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET (PHASE3)
- Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact (NA)
- Cost-effective Treatment of Unexplained Infertility (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo Comparator (for hCG) CI brief — competitive landscape report
- Placebo Comparator (for hCG) updates RSS · CI watch RSS
- Michigan State University portfolio CI